Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $72.16 -3.21%
Financial Fact:
Interest expense: -5.61M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Interest expense: -5.61M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
- Fed chair Warsh kicks off Jackson Hole keynote address
- GreenPower starts year two of New Mexico electric school bus pilot
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
